Recent Finacing
Recent Raise
Cybrexa Therapeutics is an oncology biotech developing alphalex peptide drug conjugate and tumor-specific DNA repair inhibitor programs (e.g., CBX-12, CBX-11) that target tumor microenvironment independent of antigen expression.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
